Home
About
Overview
Sharing Data
ORCID
Help
History (35)
Genetic systems in cyanobacteria.
Principal Investigator
Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial.
Meaningful disparities reduction through research and translation programs.
Practical application of anti-TNF therapy for luminal Crohn's disease.
See All 35 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Practical application of anti-TNF therapy for luminal Crohn's disease.
Practical application of anti-TNF therapy for luminal Crohn's disease. Inflamm Bowel Dis. 2011 Nov; 17(11):2366-91.
View in:
PubMed
subject areas
Antibodies, Monoclonal
Crohn Disease
Gastrointestinal Agents
Humans
Tumor Necrosis Factor-alpha
authors with profiles
Stephen B. Hanauer